AMS 700 Inflatable Penile Prosthesis (IPP)
Boston Scientific Corp · Decision date Sep 14, 2026
What did the FDA decide?
The FDA record for identifier N970012/S212 shows a 30-day notice decision (OK30) dated 2026-09-14, filed by Boston Scientific Corp. The stated change is "use of new kink resistant endcaps and process changes to accommodate those endcaps," categorized as a process change involving a manufacturer, sterilizer, packager or supplier. The product code is JCW, inflatable penile prosthesis, listed under gastroenterology and urology. The record does not describe endcap materials, dimensions, testing data, or which manufacturing steps changed.
The N970012 prefix ties the notice to the existing AMS 700 inflatable penile prosthesis PMA; S212 marks it as a supplement rather than an original approval. A manufacturing notice of this kind concerns how the device is made, and the source statement's stated purpose does not by itself establish safety or clinical effectiveness of the modified device. Because the changed steps are not specified, the scope beyond the kink-resistant endcaps and associated process adjustments remains unknown from this record.
FDA approval order statement
use of new kink resistant endcaps and process changes to accommodate those endcaps
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 14, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- N970012/S212
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific Corp
- Product code
- JCW
- Decision code
- OK30
- Decision date
- Sep 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, penis, inflatable.
- Applicant
- Boston Scientific Corp
- Product code
- JCW
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
N970012/S212 received
Application receipt date recorded by FDA.
N970012/S212 · FDA decision
30-Day Notice
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corp
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 100 Boston Scientific Way, Marlboro, MA, 01752
Sources and methodology
- Original FDA record: N970012/S212
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records